Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells.
Xu F, Zhang X, Chen Z, He S, Guo J, Yu L, Wang Y, Hou C, Ai-Furas H, Zheng Z, Smaill JB, Patterson AV, Zhang ZM, Chen L, Ren X, Ding K.
Xu F, et al. Among authors: zhang zm, zhang x.
J Med Chem. 2022 Oct 27;65(20):14032-14048. doi: 10.1021/acs.jmedchem.2c01246. Epub 2022 Sep 29.
J Med Chem. 2022.
PMID: 36173763